SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/28/24 Omega Therapeutics, Inc. 10-K 12/31/23 94:15M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.51M 3: EX-10.12 Material Contract HTML 31K 4: EX-10.13 Material Contract HTML 31K 5: EX-10.18 Material Contract HTML 54K 6: EX-10.20 Material Contract HTML 54K 7: EX-10.22 Material Contract HTML 53K 8: EX-10.33 Material Contract HTML 596K 2: EX-10.9 Material Contract HTML 123K 9: EX-23.1 Consent of Expert or Counsel HTML 27K 14: EX-97 Clawback Policy re: Recovery of Erroneously HTML 43K Awarded Compensation 10: EX-31.1 Certification -- §302 - SOA'02 HTML 33K 11: EX-31.2 Certification -- §302 - SOA'02 HTML 33K 12: EX-32.1 Certification -- §906 - SOA'02 HTML 30K 13: EX-32.2 Certification -- §906 - SOA'02 HTML 29K 16: R1 Document and Entity Information HTML 101K 17: R2 Consolidated Balance Sheets HTML 130K 18: R3 Consolidated Balance Sheets (Parenthetical) HTML 46K 19: R4 Consolidated Statements of Operations and HTML 95K Comprehensive Loss 20: R5 Consolidated Statements of Stockholders' Equity HTML 69K 21: R6 Consolidated Statements of Cash Flows HTML 128K 22: R7 Pay vs Performance Disclosure HTML 39K 23: R8 Insider Trading Arrangements HTML 33K 24: R9 Nature of the Business and Basis of Presentation HTML 42K 25: R10 Summary of Significant Accounting Policies HTML 89K 26: R11 Marketable Securities HTML 50K 27: R12 Prepaid Expenses and Other Current Assets HTML 52K 28: R13 Property and Equipment, Net HTML 54K 29: R14 Accrued Expenses HTML 50K 30: R15 Term Loan HTML 75K 31: R16 Fair Value of Financial Instruments HTML 99K 32: R17 Commitments and Contingencies HTML 99K 33: R18 License Agreements HTML 53K 34: R19 Collaboration Agreement HTML 46K 35: R20 Preferred and Common Stock HTML 39K 36: R21 Equity Incentive Plans HTML 115K 37: R22 Net Loss Per Share Attributable to Common HTML 53K Stockholders 38: R23 Income Taxes HTML 99K 39: R24 Related Party Transactions HTML 47K 40: R25 Employee Benefits HTML 32K 41: R26 Summary of Significant Accounting Policies HTML 148K (Policies) 42: R27 Summary of Significant Accounting Policies HTML 33K (Tables) 43: R28 Marketable Securities (Tables) HTML 45K 44: R29 Prepaid Expenses and Other Current Assets (Tables) HTML 52K 45: R30 Property and Equipment, Net (Tables) HTML 52K 46: R31 Accrued Expenses (Tables) HTML 49K 47: R32 Term Loan (Tables) HTML 64K 48: R33 Fair Value of Financial Instruments (Tables) HTML 150K 49: R34 Commitments and Contingencies (Tables) HTML 77K 50: R35 Equity Incentive Plans (Tables) HTML 102K 51: R36 Net Loss Per Share Attributable to Common HTML 54K Stockholders (Tables) 52: R37 Income Taxes (Tables) HTML 91K 53: R38 Nature of the Business and Basis of Presentation - HTML 53K Additional Information (Details) 54: R39 Summary of Significant Accounting Policies - HTML 65K Additional Information (Details) 55: R40 Summary of Significant Accounting Policies - HTML 37K Summary of Estimated Useful Life of Each Asset Category (Details) 56: R41 Marketable Securities - Summary of Marketable HTML 39K Securities (Details) 57: R42 Marketable Securities - Additional Information HTML 35K (Details) 58: R43 Prepaid Expenses and Other Current Assets - HTML 42K Summary of Prepaid Expenses and other Current Assets (Details) 59: R44 Property and Equipment, Net - Summary of Property HTML 46K and Equipment, Net (Details) 60: R45 Property and Equipment, Net - Additional HTML 29K Information (Details) 61: R46 Accrued Expenses - Summary of Accrued Expenses HTML 41K (Details) 62: R47 Term Loan - Additional Information (Details) HTML 82K 63: R48 Term Loan - Summary of Outstanding Term Loan HTML 36K Balance (Details) 64: R49 Term Loan - Summary of Interest Expense Recognized HTML 35K Related to Term loan (Details) 65: R50 Term Loan - Schedule of Principal Amount in HTML 41K Connection With Term Loan (Details) 66: R51 Fair Value of Financial Instruments - Summary of HTML 47K Fair Value of Financial Instruments (Details) 67: R52 Fair Value of Financial Instruments - Additional HTML 35K Information (Details) 68: R53 Fair Value of Financial Instruments - Summary of HTML 42K Significant Quantitative Inputs Used to Determine Valuation of Success Fee Obligation (Details) 69: R54 Fair Value of Financial Instruments - Summary of HTML 40K Fair Values of Success Fee Obligation (Details) 70: R55 Commitments and Contingencies - Additional HTML 165K Information (Details) 71: R56 Commitments and Contingencies - Summary of HTML 34K Components of Lease Expense (Details) 72: R57 Commitments and Contingencies - Summary of HTML 32K Weighted Average Remaining Lease Term And Discount Rate Related to Leases (Details) 73: R58 Commitments and Contingencies - Summary of HTML 32K Supplemental Cash Flow Information Relating to Leases (Details) 74: R59 Commitments and Contingencies - Summary of HTML 46K Estimated Minimum Lease Payments (Details) 75: R60 License Agreements - Additional Information HTML 86K (Details) 76: R61 Collaboration Agreement - Additional Information HTML 49K (Details) 77: R62 Redeemable Convertible Preferred Stock - HTML 34K Additional Information (Details) 78: R63 Preferred and Common Stock - Additional HTML 73K Information (Details) 79: R64 Equity Incentive Plans - Additional Information HTML 82K (Details) 80: R65 Equity Incentive Plans - Summary of Stock-based HTML 34K Compensation Expense (Details) 81: R66 Equity Incentive Plans - Summary of Assumptions HTML 39K Used in Black-Scholes Option-pricing Model for Stock Options (Details) 82: R67 Equity Incentive Plans - Summary of Option HTML 87K Activity (Details) 83: R68 Net Loss Per Share Attributable to Common HTML 59K Stockholders - Summary of the Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) 84: R69 Net Loss Per Share Attributable to Common HTML 32K Stockholders - Schedule of Anti-Dilutive Securities Excluded from Computation of Earnings Per Share (Details) 85: R70 Income Taxes - Summary of Reconciliation of HTML 45K Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) 86: R71 Income Taxes - Summary of Components of Deferred HTML 59K Taxes (Details) 87: R72 Income Taxes - Additional Information (Details) HTML 49K 88: R73 Related Party Transactions - Additional HTML 87K Information (Details) 89: R74 Employee Benefits - Additional Information HTML 36K (Details) 91: XML IDEA XML File -- Filing Summary XML 172K 94: XML XBRL Instance -- omga-20231231_htm XML 1.87M 90: EXCEL IDEA Workbook of Financial Report Info XLSX 126K 15: EX-101.SCH XBRL Taxonomy Extension Schema With Embedded XSD 4.22M Linkbases Document -- omga-20231231 92: JSON XBRL Instance as JSON Data -- MetaLinks 643± 934K 93: ZIP XBRL Zipped Folder -- 0000950170-24-038094-xbrl Zip 1.55M
Download this Microsoft® Excel® .xlsx workbook |